Alibaba participated in the cancer diagnostic kit provider's first funding round in over a year, pushing its overall funding past $230m.

China-based cancer screening service provider Creative Biosciences has secured $87m in a series D round led by e-commerce group Alibaba, DealStreetAsia reported on Friday.

Financial services firm Agriculture Bank of China’s ABC International subsidiary also took part in the round, alongside Huaxing Growth Capital, Costone Capital, Henglu Asset and IDG Capital.

Creative Biosciences provides early-stage cancer screening diagnostic kits for a range of cancers including lung, liver, bladder, cervix and colorectal.

The company raised $88m in a September 2020…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
Email LinkedIn